ID   PADI3_HUMAN             Reviewed;         664 AA.
AC   Q9ULW8; Q58EY7; Q70SX5;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 2.
DT   10-MAY-2017, entry version 138.
DE   RecName: Full=Protein-arginine deiminase type-3;
DE            EC=3.5.3.15 {ECO:0000269|PubMed:27866708};
DE   AltName: Full=Peptidylarginine deiminase III;
DE   AltName: Full=Protein-arginine deiminase type III;
GN   Name=PADI3; Synonyms=PAD3, PDI3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   TISSUE=Keratinocyte;
RX   PubMed=11069618; DOI=10.1046/j.1523-1747.2000.00131.x;
RA   Kanno T., Kawada A., Yamanouchi J., Yosida-Noro C., Yoshiki A.,
RA   Shiraiwa M., Kusakabe M., Manabe M., Tezuka T., Takahara H.;
RT   "Human peptidylarginine deiminase type III: molecular cloning and
RT   nucleotide sequence of the cDNA, properties of the recombinant enzyme,
RT   and immunohistochemical localization in human skin.";
RL   J. Invest. Dermatol. 115:813-823(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=15087120; DOI=10.1016/j.gene.2003.12.038;
RA   Chavanas S., Mechin M.-C., Takahara H., Kawada A., Nachat R.,
RA   Serre G., Simon M.;
RT   "Comparative analysis of the mouse and human peptidylarginine
RT   deiminase gene clusters reveals highly conserved non-coding segments
RT   and a new human gene, PADI6.";
RL   Gene 330:19-27(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-509.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [6]
RP   INVOLVEMENT IN UHS1, VARIANTS UHS1 HIS-112; VAL-294 AND THR-605,
RP   CHARACTERIZATION OF VARIANTS UHS1 HIS-112 AND THR-605, SUBCELLULAR
RP   LOCATION, CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=27866708; DOI=10.1016/j.ajhg.2016.10.004;
RA   Ue Basmanav F.B., Cau L., Tafazzoli A., Mechin M.C., Wolf S.,
RA   Romano M.T., Valentin F., Wiegmann H., Huchenq A., Kandil R.,
RA   Garcia Bartels N., Kilic A., George S., Ralser D.J., Bergner S.,
RA   Ferguson D.J., Oprisoreanu A.M., Wehner M., Thiele H., Altmueller J.,
RA   Nuernberg P., Swan D., Houniet D., Buechner A., Weibel L., Wagner N.,
RA   Grimalt R., Bygum A., Serre G., Blume-Peytavi U., Sprecher E.,
RA   Schoch S., Oji V., Hamm H., Farrant P., Simon M., Betz R.C.;
RT   "Mutations in three genes encoding proteins involved in hair shaft
RT   formation cause uncombable hair syndrome.";
RL   Am. J. Hum. Genet. 99:1292-1304(2016).
CC   -!- FUNCTION: Catalyzes the deimination of arginine residues of
CC       proteins. {ECO:0000269|PubMed:27866708}.
CC   -!- CATALYTIC ACTIVITY: Protein L-arginine + H(2)O = protein L-
CC       citrulline + NH(3). {ECO:0000269|PubMed:27866708}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-10488185, EBI-10488185;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:27866708}.
CC   -!- TISSUE SPECIFICITY: Hair follicles, and epidermis at very low
CC       levels.
CC   -!- DISEASE: Uncombable hair syndrome 1 (UHS1) [MIM:191480]: A form of
CC       uncombable hair syndrome, a condition characterized by scalp hair
CC       that is impossible to comb due to the haphazard arrangement of the
CC       hair bundles. A characteristic morphologic feature is a triangular
CC       to reniform to heart shape on cross-sections, and a groove, canal
CC       or flattening along the entire length of the hair. Most
CC       individuals are affected early in childhood and the hair takes on
CC       a spun-glass appearance with the hair becoming dry, curly, glossy,
CC       lighter in color, and progressively uncombable. The hair growth
CC       rate can range from slow to normal, and the condition improves
CC       with age. UHS1 inheritance is autosomal dominant.
CC       {ECO:0000269|PubMed:27866708}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein arginine deiminase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB026831; BAA85974.1; -; mRNA.
DR   EMBL; AJ549502; CAE47742.1; -; Genomic_DNA.
DR   EMBL; AL590644; CAH73166.1; -; Genomic_DNA.
DR   EMBL; BC041592; AAH41592.1; -; mRNA.
DR   EMBL; BC109091; AAI09092.1; -; mRNA.
DR   EMBL; BC109092; AAI09093.1; -; mRNA.
DR   CCDS; CCDS179.1; -.
DR   RefSeq; NP_057317.2; NM_016233.2.
DR   UniGene; Hs.149195; -.
DR   ProteinModelPortal; Q9ULW8; -.
DR   SMR; Q9ULW8; -.
DR   BioGrid; 119686; 17.
DR   IntAct; Q9ULW8; 2.
DR   STRING; 9606.ENSP00000364609; -.
DR   BindingDB; Q9ULW8; -.
DR   ChEMBL; CHEMBL1909488; -.
DR   DrugBank; DB00155; L-Citrulline.
DR   iPTMnet; Q9ULW8; -.
DR   PhosphoSitePlus; Q9ULW8; -.
DR   BioMuta; PADI3; -.
DR   DMDM; 56757696; -.
DR   EPD; Q9ULW8; -.
DR   MaxQB; Q9ULW8; -.
DR   PaxDb; Q9ULW8; -.
DR   PeptideAtlas; Q9ULW8; -.
DR   PRIDE; Q9ULW8; -.
DR   TopDownProteomics; Q9ULW8; -.
DR   Ensembl; ENST00000375460; ENSP00000364609; ENSG00000142619.
DR   Ensembl; ENST00000625769; ENSP00000486702; ENSG00000280549.
DR   GeneID; 51702; -.
DR   KEGG; hsa:51702; -.
DR   UCSC; uc001bai.4; human.
DR   CTD; 51702; -.
DR   DisGeNET; 51702; -.
DR   GeneCards; PADI3; -.
DR   HGNC; HGNC:18337; PADI3.
DR   HPA; HPA043739; -.
DR   MIM; 191480; phenotype.
DR   MIM; 606755; gene.
DR   neXtProt; NX_Q9ULW8; -.
DR   OpenTargets; ENSG00000142619; -.
DR   PharmGKB; PA32901; -.
DR   eggNOG; ENOG410IF3F; Eukaryota.
DR   eggNOG; ENOG410ZKF3; LUCA.
DR   GeneTree; ENSGT00390000008680; -.
DR   HOGENOM; HOG000220908; -.
DR   HOVERGEN; HBG053016; -.
DR   InParanoid; Q9ULW8; -.
DR   KO; K01481; -.
DR   OMA; NDLNDSH; -.
DR   OrthoDB; EOG091G02QG; -.
DR   PhylomeDB; Q9ULW8; -.
DR   TreeFam; TF331952; -.
DR   BioCyc; MetaCyc:HS06944-MONOMER; -.
DR   BRENDA; 3.5.3.15; 2681.
DR   Reactome; R-HSA-3247509; Chromatin modifying enzymes.
DR   GeneWiki; PADI3; -.
DR   GenomeRNAi; 51702; -.
DR   PRO; PR:Q9ULW8; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000142619; -.
DR   CleanEx; HS_PADI3; -.
DR   Genevisible; Q9ULW8; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004668; F:protein-arginine deiminase activity; IMP:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; TAS:Reactome.
DR   GO; GO:0036414; P:histone citrullination; IBA:GO_Central.
DR   GO; GO:0018101; P:protein citrullination; IMP:UniProtKB.
DR   Gene3D; 2.60.40.1700; -; 1.
DR   InterPro; IPR008972; Cupredoxin.
DR   InterPro; IPR004303; PAD.
DR   InterPro; IPR013530; PAD_C.
DR   InterPro; IPR013732; PAD_N.
DR   InterPro; IPR013733; Prot_Arg_deaminase_cen_dom.
DR   PANTHER; PTHR10837; PTHR10837; 1.
DR   Pfam; PF03068; PAD; 1.
DR   Pfam; PF08527; PAD_M; 1.
DR   Pfam; PF08526; PAD_N; 1.
DR   PIRSF; PIRSF001247; Protein-arginine_deiminase; 1.
DR   SUPFAM; SSF110083; SSF110083; 1.
DR   SUPFAM; SSF49503; SSF49503; 1.
PE   1: Evidence at protein level;
KW   Calcium; Complete proteome; Cytoplasm; Disease mutation; Hydrolase;
KW   Polymorphism; Reference proteome.
FT   CHAIN         1    664       Protein-arginine deiminase type-3.
FT                                /FTId=PRO_0000220029.
FT   VARIANT      52     52       I -> V (in dbSNP:rs3750300).
FT                                /FTId=VAR_020462.
FT   VARIANT     112    112       L -> H (in UHS1; forms large aggregates;
FT                                decreases protein-arginine deiminase
FT                                activity). {ECO:0000269|PubMed:27866708}.
FT                                /FTId=VAR_078023.
FT   VARIANT     171    171       V -> M (in dbSNP:rs2272629).
FT                                /FTId=VAR_020463.
FT   VARIANT     294    294       A -> V (in UHS1; forms large aggregates;
FT                                decreases protein-arginine deiminase
FT                                activity). {ECO:0000269|PubMed:27866708}.
FT                                /FTId=VAR_078024.
FT   VARIANT     509    509       G -> R (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs781009577).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035502.
FT   VARIANT     582    582       A -> T (in dbSNP:rs34097903).
FT                                /FTId=VAR_053558.
FT   VARIANT     605    605       P -> T (in UHS1; forms large aggregates;
FT                                decreases protein-arginine deiminase
FT                                activity). {ECO:0000269|PubMed:27866708}.
FT                                /FTId=VAR_078025.
FT   VARIANT     618    618       R -> Q (in dbSNP:rs35624745).
FT                                /FTId=VAR_053559.
FT   CONFLICT    480    480       A -> V (in Ref. 1; BAA85974).
FT                                {ECO:0000305}.
SQ   SEQUENCE   664 AA;  74743 MW;  90C22A50BF6FD480 CRC64;
     MSLQRIVRVS LEHPTSAVCV AGVETLVDIY GSVPEGTEMF EVYGTPGVDI YISPNMERGR
     ERADTRRWRF DATLEIIVVM NSPSNDLNDS HVQISYHSSH EPLPLAYAVL YLTCVDISLD
     CDLNCEGRQD RNFVDKRQWV WGPSGYGGIL LVNCDRDDPS CDVQDNCDQH VHCLQDLEDM
     SVMVLRTQGP AALFDDHKLV LHTSSYDAKR AQVFHICGPE DVCEAYRHVL GQDKVSYEVP
     RLHGDEERFF VEGLSFPDAG FTGLISFHVT LLDDSNEDFS ASPIFTDTVV FRVAPWIMTP
     STLPPLEVYV CRVRNNTCFV DAVAELARKA GCKLTICPQA ENRNDRWIQD EMELGYVQAP
     HKTLPVVFDS PRNGELQDFP YKRILGPDFG YVTREPRDRS VSGLDSFGNL EVSPPVVANG
     KEYPLGRILI GGNLPGSSGR RVTQVVRDFL HAQKVQPPVE LFVDWLAVGH VDEFLSFVPA
     PDGKGFRMLL ASPGACFKLF QEKQKCGHGR ALLFQGVVDD EQVKTISINQ VLSNKDLINY
     NKFVQSCIDW NREVLKRELG LAECDIIDIP QLFKTERKKA TAFFPDLVNM LVLGKHLGIP
     KPFGPIINGC CCLEEKVRSL LEPLGLHCTF IDDFTPYHML HGEVHCGTNV CRKPFSFKWW
     NMVP
//
